Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06130995
Title Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stephenson Cancer Center at OU Health, University of Oklahoma Health Sciences Center (SCC-OUHSC) Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field